Literature DB >> 7515171

Stem cell factor is a potent synergistic factor in hematopoiesis.

G Morstyn1, S Brown, M Gordon, J Crawford, G Demetri, W Rich, B McGuire, M Foote, I McNiece.   

Abstract

Stem cell factor (SCF), a ligand for c-kit, has a broad range of activities including effects on cells at or near the level of the multipotential stem cell as well as on committed cells. Preclinical studies show that SCF can protect against lethal irradiation, elicit multilineage responses in peripheral blood and bone marrow cellularity, and increase circulating peripheral blood progenitor cells (PBPC) in a dose-dependent manner. Recombinant human SCF has major clinical potential through its synergy with other factors, especially recombinant human granulocyte colony-stimulating factor, to enhance mobilization of PBPC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515171     DOI: 10.1159/000227335

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

Review 1.  The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man.

Authors:  Daniel A Zlotoff; Benjamin A Schwarz; Avinash Bhandoola
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

2.  Human granulocyte-colony stimulating factor (G-CSF)/stem cell factor (SCF) fusion proteins: design, characterization and activity.

Authors:  Gitana Mickiene; Indrė Dalgėdienė; Gintautas Zvirblis; Zilvinas Dapkunas; Ieva Plikusiene; Ernesta Buzavaite-Verteliene; Zigmas Balevičius; Audronė Rukšėnaitė; Milda Pleckaityte
Journal:  PeerJ       Date:  2020-08-21       Impact factor: 2.984

3.  Deficiency in Fpr2 results in reduced numbers of Lin-cKit+Sca1+ myeloid progenitor cells.

Authors:  Keqiang Chen; Peng Tang; Zhiyao Bao; Tianzhen He; Yi Xiang; Wanghua Gong; Teizo Yoshimura; Yingying Le; Lino Tessarollo; Xin Chen; Ji Ming Wang
Journal:  J Biol Chem       Date:  2018-07-17       Impact factor: 5.157

4.  The role of c-kit and imatinib mesylate in uveal melanoma.

Authors:  Patricia Rusa Pereira; Alexandre Nakao Odashiro; Jean Claude Marshall; Zelia Maria Correa; Rubens Belfort; Miguel N Burnier
Journal:  J Carcinog       Date:  2005-10-19

5.  Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.

Authors:  J J Costa; G D Demetri; T J Harrist; A M Dvorak; D F Hayes; E A Merica; D M Menchaca; A J Gringeri; L B Schwartz; S J Galli
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

Review 6.  Mobilized peripheral blood: an updated perspective.

Authors:  Darja Karpova; Michael P Rettig; John F DiPersio
Journal:  F1000Res       Date:  2019-12-20

7.  Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.

Authors:  Anikó Balogh; Tibor Milibák; Viktória Szabó; Zoltán Zsolt Nagy; Miklós D Resch
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

Review 8.  A Review of Advances in Hematopoietic Stem Cell Mobilization and the Potential Role of Notch2 Blockade.

Authors:  Marwah Albakri; Hammad Tashkandi; Lan Zhou
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.